Biologically Inspired Engineering, synbio, synthetic biology, crispr
Staff 
Each new presidential administration appoints thousands of new people to political positions inside the new government. The Biden administration has been busy recruiting and vetting candidates for various positions, some of which will advise the president on matters related to science. Francis Collins, M.D., Ph.D., will continue in his role as National Institutes of Health … Read more
The COVID-19 pandemic may soon push scientists towards work against cancer, autoimmune diseases and other illnesses. The vaccines from drug companies Moderna and Pfizer-BioNTech use a new way to train the body’s immune system to respond to infection. They are testing the same techniques to recruit the immune system to attack tumors. And when immune … Read more
Glycobiology crosses many fields including chemistry, biology, medicine, and materials science. Broadly speaking, glycobiology is the study of the structure, biosynthesis and biology of glycans (carbohydrates). All cells and many proteins are covered with a dense and complex array of covalently attached sugar chains (called oligosaccharides or glycans). The biological roles of these glycans become particularly important … Read more
According to Dr. Francis Collins, evolutionary studies – comparing the development of these systems across animals and organisms – are now leading to unexpected biological discoveries and promising possibilities for preventing and treating human disease. While there are many evolutionary questions to ask, Brenda Bass, a distinguished biochemist at University of Utah, Salt Lake City, … Read more
The Defense Advanced Research Projects Agency (DARPA), established in 1958, is an agency within the Department of Defense (DOD) responsible for catalyzing the development of technologies that maintain and advance the capabilities and technical superiority of the U.S. military. In short, it’s the way the U.S. military tries to prevent technical surprise. The Nucleic acids … Read more
Recursion Pharmaceuticals Inc. uses machine learning to hunt for new therapies. The company raised $436 million in an upsized initial public offering priced at the top of a marketed range. Last week , the Salt Lake City-based company sold about 24 million shares for $18 each. Recursion is among a crop of new startups called … Read more
Proteogenomic has the potential to match cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma (HNSCC) that could be used to better determine appropriate treatment. The research led by Baylor College of Medicine, Johns Hopkins University and the National Cancer … Read more
Where is cancer research headed in the next decade? Scientists and oncologists at the National Cancer Institute share their thoughts on proteogenomics. Oncology has experienced more constant change in the last 30 years than from the late 20th century to the time cancer was first identified in 440 B.C. The rapid pace of innovation in … Read more
Synthetic biology starts and ends with data, and it’s no secret that the human immune system is migrating to the cloud. Cleveland Clinic and IBM have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic – IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and … Read more
Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III, a special purpose acquisition company or SPAC, sponsored by Perceptive Advisors, announced in February a definitive business combination agreement. The combined company is expected to receive proceeds of approximately $350 million at the closing … Read more